210 related articles for article (PubMed ID: 11906971)
1. The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects.
Krobert KA; Levy FO
Br J Pharmacol; 2002 Mar; 135(6):1563-71. PubMed ID: 11906971
[TBL] [Abstract][Full Text] [Related]
2. Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719.
Thomas DR; Gittins SA; Collin LL; Middlemiss DN; Riley G; Hagan J; Gloger I; Ellis CE; Forbes IT; Brown AM
Br J Pharmacol; 1998 Jul; 124(6):1300-6. PubMed ID: 9720804
[TBL] [Abstract][Full Text] [Related]
3. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation.
Adham N; Zgombick JM; Bard J; Branchek TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):508-14. PubMed ID: 9808674
[TBL] [Abstract][Full Text] [Related]
5. Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b).
Jasper JR; Kosaka A; To ZP; Chang DJ; Eglen RM
Br J Pharmacol; 1997 Sep; 122(1):126-32. PubMed ID: 9298538
[TBL] [Abstract][Full Text] [Related]
6. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
Krobert KA; Andressen KW; Levy FO
Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of an adenylyl cyclase-coupled 5-HT receptor in aplysia: comparison with mammalian 5-HT receptors.
Cohen JE; Onyike CU; McElroy VL; Lin AH; Abrams TW
J Neurophysiol; 2003 Mar; 89(3):1440-55. PubMed ID: 12611939
[TBL] [Abstract][Full Text] [Related]
8. The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution.
Krobert KA; Bach T; Syversveen T; Kvingedal AM; Levy FO
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):620-32. PubMed ID: 11414657
[TBL] [Abstract][Full Text] [Related]
9. Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells.
Labrecque J; Fargin A; Bouvier M; Chidiac P; Dennis M
Mol Pharmacol; 1995 Jul; 48(1):150-9. PubMed ID: 7623769
[TBL] [Abstract][Full Text] [Related]
10. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes.
Newman-Tancredi A; Cussac D; Quentric Y; Touzard M; Verrièle L; Carpentier N; Millan MJ
J Pharmacol Exp Ther; 2002 Nov; 303(2):815-22. PubMed ID: 12388668
[TBL] [Abstract][Full Text] [Related]
11. Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction.
Chanrion B; Mannoury la Cour C; Gavarini S; Seimandi M; Vincent L; Pujol JF; Bockaert J; Marin P; Millan MJ
Mol Pharmacol; 2008 Mar; 73(3):748-57. PubMed ID: 18083778
[TBL] [Abstract][Full Text] [Related]
12. Transfection of human 5-hydroxytryptamine1A receptors in NIH-3T3 fibroblasts: effects of increasing receptor density on the coupling of 5-hydroxytryptamine1A receptors to adenylyl cyclase.
Varrault A; Journot L; Audigier Y; Bockaert J
Mol Pharmacol; 1992 Jun; 41(6):999-1007. PubMed ID: 1614416
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase.
Plassat JL; Amlaiky N; Hen R
Mol Pharmacol; 1993 Aug; 44(2):229-36. PubMed ID: 8394987
[TBL] [Abstract][Full Text] [Related]
14. Differences in agonist-independent and -dependent 5-hydroxytryptamine2C receptor-mediated cell division.
Westphal RS; Sanders-Bush E
Mol Pharmacol; 1996 Mar; 49(3):474-80. PubMed ID: 8643087
[TBL] [Abstract][Full Text] [Related]
15. The 5-HT4 receptor antagonist ML10375 inhibits the constitutive activity of human 5-HT4(c) receptor.
Blondel O; Gastineau M; Langlois M; Fischmeister R
Br J Pharmacol; 1998 Oct; 125(4):595-7. PubMed ID: 9831890
[TBL] [Abstract][Full Text] [Related]
16. Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors.
Mahé C; Loetscher E; Feuerbach D; Müller W; Seiler MP; Schoeffter P
Eur J Pharmacol; 2004 Jul; 495(2-3):97-102. PubMed ID: 15249157
[TBL] [Abstract][Full Text] [Related]
17. Involvement of 5-hydroxytryptamine7 receptors in inhibition of porcine myometrial contractility by 5-hydroxytryptamine.
Kitazawa T; Kubo O; Satoh M; Taneike T
Br J Pharmacol; 1998 Jan; 123(2):173-82. PubMed ID: 9489604
[TBL] [Abstract][Full Text] [Related]
18. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM
Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797
[TBL] [Abstract][Full Text] [Related]
19. Cloning, genomic organization and functionality of 5-HT(7) receptor splice variants from mouse brain.
Gellynck E; Laenen K; Andressen KW; Lintermans B; De Martelaere K; Matthys A; Levy FO; Haegeman G; Vanhoenacker P; Van Craenenbroeck K
Gene; 2008 Dec; 426(1-2):23-31. PubMed ID: 18793707
[TBL] [Abstract][Full Text] [Related]
20. Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties.
Rauly-Lestienne I; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Cussac D
Naunyn Schmiedebergs Arch Pharmacol; 2007 Oct; 376(1-2):93-105. PubMed ID: 17786406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]